1. Almquist KC, Loe DW, Hipfner DR et al. (1995). Characterization of the Mr 190,000 multidrug resistance protein ( Mrp) in drug-selected and transfected human tumor cells. Cancer Res 55: 102–110.
2. Deeley RG, Cole SP (1997). Function, evolution and structure of multidrug resistance protein ( MRP ). Semin Cancer Biol 8: 193–204.
3. Doyle LA, Yang W, Abruzzo LV et al. (1998). A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 95: 15665–15670.
4. Frey T, Yue S, Haugland RP (1995). Dyes providing increased sensitivity in flow-cytometric dye-efflux assays for multidrug resistance. Cytometry 20: 218–227.
5. Ganapathi R, Grabowski D, Rouse W et al. (1981). Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells. Cancer Res 44: 5056–5061.